Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment
Open Access
- 1 July 1994
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (28) , 18327-18331
- https://doi.org/10.1016/s0021-9258(17)32310-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3Proteins-Structure Function and Bioinformatics, 1994
- Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regionsBiochemistry, 1994
- A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.Proceedings of the National Academy of Sciences, 1993
- Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.Proceedings of the National Academy of Sciences, 1992
- Recombinant Toxins for Cancer TreatmentScience, 1991
- B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.Proceedings of the National Academy of Sciences, 1991
- A comparison of strategies to stabilize immunoglobulin Fv-fragmentsBiochemistry, 1990
- A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinNature, 1989
- Single-Chain Antigen-Binding ProteinsScience, 1988
- Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.Proceedings of the National Academy of Sciences, 1988